Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
-
- Jennifer G. Robinson
- Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City
-
- Bettina S. Nedergaard
- Center for Clinical and Basic Research, Aalborg, Denmark
-
- William J. Rogers
- Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham
-
- Jonathan Fialkow
- Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami
-
- Joel M. Neutel
- Orange County Research Center, Tustin, California
-
- David Ramstad
- Hampton Roads Center for Clinical Research, Suffolk, Virginia
-
- Ransi Somaratne
- Amgen Inc, Thousand Oaks, California
-
- Jason C. Legg
- Amgen Inc, Thousand Oaks, California
-
- Patric Nelson
- Amgen Inc, Thousand Oaks, California
-
- Rob Scott
- Amgen Inc, Thousand Oaks, California
-
- Scott M. Wasserman
- Amgen Inc, Thousand Oaks, California
-
- Robert Weiss
- Maine Research Associates, Auburn
書誌事項
- タイトル別名
-
- The LAPLACE-2 Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 311 (18), 1870-, 2014-05-14
American Medical Association (AMA)